SHL Medical, a Swiss provider of self-injection solutions, announced on Thursday that it is planning to establish SHL Advantec, a sub-group dedicated to providing tooling and automation solutions to the healthcare sector and other industries.
SHL Advantec will be headquartered in Zug, Switzerland and will commence operations with more than 600 employees across its offices and production sites in Switzerland, China, Taiwan, Mexico and the United States.
SHL Medical's existing tooling and automation operations will be integrated into SHL Advantec, bringing its range of technologies, services and equipment portfolio to the new business. Together with SHL Medical's recent strategic acquisitions -- Swiss-based LCA Automation and SMC Mould Innovation and US-based Superior Tooling -- SHL Advantec will form a global operations network spanning three continents to deliver faster support and shorter supply chain services to SHL Advantec's diverse customer base. Leveraging its experience in medical devices and other industries, SHL Advantec says that it will focus on helping its customers advance production quality and resilience while continuing to support SHL Medical's growth in autoinjector manufacturing.
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
MAP Medical agrees distribution deal with Metrix-Secure
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement